Checkpoint Therapeutics Inc (CKPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,604 | 4,928 | 12,068 | 54,735 | 40,772 |
| Receivables | N/A | N/A | 73 | 17 | 20 |
| TOTAL | $7,471 | $5,378 | $13,290 | $55,728 | $42,596 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $7,471 | $5,378 | $13,290 | $55,728 | $42,596 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,898 | 18,300 | 21,603 | 25,982 | 7,217 |
| Other current liabilities | 198 | 125 | 11,170 | N/A | N/A |
| TOTAL | $20,096 | $18,425 | $32,773 | $25,982 | $7,217 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $20,096 | $18,425 | $32,773 | $25,982 | $7,217 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,764 | 35,686 | 12,947 | 9,059 | 7,521 |
| Common Shares | 5 | 3 | 1 | 1 | 7 |
| Retained earnings | -370,573 | -314,333 | -262,486 | -199,862 | -143,192 |
| Other shareholders' equity | 7,638 | 3,419 | 1,885 | 6,598 | 4,617 |
| TOTAL | $-12,625 | $-13,047 | $-19,483 | $29,746 | $35,379 |
| Total Liabilities And Equity | $7,471 | $5,378 | $13,290 | $55,728 | $42,596 |